Skip to contentI
Innoviva, Inc.
I
INVAInnoviva, Inc. Q3 2025 · 10-Q
Revenue$107.80M$107.80M+20.4% vs Q3 2024 Net Income$89.91M$89.91M+7,312.0% vs Q3 2024 EPS Diluted$1.08$1.08+5,300.0% vs Q3 2024 Gross Profit$75,539,000+3.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Innoviva, Inc. · CIK 1080014 · Engraved from SEC EDGAR
Operating Cash Flowderived$49,727,000+2.1% Free Cash Flowderived$48,606,000+0.4% Margins · derivedGross margin70.1%−11.5 pt vs Q3 2024
Operating margin32.1%−16.2 pt vs Q3 2024
Net margin83.4%+82.0 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 5, 2025 · 36 d after period end